Monitoring the ingestion of anti-tuberculosis drugs by simple non-invasive methods

International Journal of Pharmaceutics

Volumn 307, Issue 2, 2006, Pages 182-187

  Sirgel, F A ^a   Maritz, J S ^b   Venter, A ^a   Langdon, G ^c   Smith, P J ^d   Donald, P R ^e  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^c UPPSALA UNIVERSITY   (Sweden)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

^e Department of Paediatrics and Child Health ^*  (South Africa)

Author keywords

Anti tuberculosis drugs; Monitoring adherence; Urine testing

Indexed keywords

BUTANOL; DRUG METABOLITE; ISONIAZID; ISONICOTINIC ACID; ISONICOTINYLGLYCINE; RIFAMPICIN; RIFAMYCIN; RIFAPENTINE; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ARTICLE; DRUG MONITORING; EXTRACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INGESTION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MICROBIOLOGY; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; TEST STRIP; URINALYSIS; VALIDATION PROCESS;

ANTITUBERCULAR AGENTS; DRUG MONITORING; HUMANS; ISONIAZID; ISONICOTINIC ACIDS; MICROBIAL SENSITIVITY TESTS; PATIENT COMPLIANCE; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RIFAMPIN; SELF ADMINISTRATION; STAPHYLOCOCCUS AUREUS;

EID: 29244444236     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2005.09.033     Document Type: Article

References (26)

1. G. Acocella Clinical pharmacokinetics of rifampicin Clin. Pharmacokinet 3 2 1978 108 127
2. K.R. Burkardt, and E.E. Nel Monitoring regularity of drug intake in tuberculous patients by means of simple urine tests S. Afr. Med. J. 57 1980 981 985
3. E.D. Chan, and M.D. Iseman Current medical treatment for tuberculosis Br. Med. J. 325 2002 1282 1286
4. P.R. Donald, F.A. Sirgel, A. Venter, E. Smit, D.P. Parkin, B.W. Van de Wal, C.J. Doré, and D.A. Mitchison The early bactericidal activity of streptomycin Int. J. Tuberc. Lung Dis. 6 8 2002 693 698
5. P.R. Donald, F.A. Sirgel, A. Venter, D.P. Parkin, H.I. Seifart, B.W. van de Wal, J.S. Maritz, and P.B. Fourie Early bactericidal activity of anti-tuberculosis agents Expert. Rev. Anti-infect. Ther. 1 2003 141 155
6. J. Elizaga, and J.S. Friedland Monitoring compliance with antituberculous treatment by detection of isoniazid in urine The Lancet. 350 1997 1225 1226
7. G.A. Ellard, and C. Greenfield A sensitive urine-test method for monitoring the ingestion of isoniazid J. Clin. Path. 30 1977 84 87
8. J.O. Kilburn, R.E. Beam, H.L. David, E. Sanchez, R.F. Corpe, and W. Dunn Reagent-impregnated paper strip for detection of metabolic products of isoniazid in urine Am. Rev. Respir. Dis. 106 1972 923 924
9. M.E. Kimberling, P. Phillips, P. Patterson, M. Hall, C.A. Robinson, and N.E. Dunlap Low serum antimycobacterial drug levels in non-HIV-infected tuberculosis patients Chest 113 1998 1178 1183
10. A. Kucers Part 1, antibiotics: rifampicin (rifampin) A. Kucers S.M. Crowe M.L. Grayson J.F. Hoy The use of Antibiotics. A Clinical Review of Antibacterial, Antifungal and Antiviral Drugs fifth ed. 1997 Butterworth Heinemann 676 708
11. G. Langdon, J.J. Wilkins, P.J. Smith, and H. McLlleron Consecutive-dose pharmacokinetics of rifapentine in patients diagnosed with pulmonary tuberculosis Int. J. Tuberc. Lung Dis. 8 7 2004 862 867
12. Y.-C. Liu, W.-K. Huang, T.-S. Huang, and C.M. Kunin Detection of antimicrobial activity in urine for epidemiologic studies of antibiotic use J. Clin. Epidemiol. 52 6 1999 539 545
13. H. McIlleron, P. Wash, A. Burger, P. Folb, and P. Smith Widespread distribution of a single drug rifampicin formulation of inferior bioavailability in South Africa Int. J. Tuberc. Lung Dis. 6 4 2002 356 361
14. J.B. Mehta, H. Shantaveerapa, R.P. Byrd Jr., S.E. Morton, F. Fountain, and T.M. Roy Utility of rifampin blood levels in the treatment and follow-up of active pulmonary tuberculosis in patients who were slow to respond to routine directly observed therapy Chest 120 2001 1520 1524
15. P.E. Meissner, P. Musoke, A. Okwera, J.E.G. Bunn, and J.B.S. Coulter The value of urine testing for verifying adherence to anti-tuberculosis chemotherapy in children and adults in Uganda Int. J. Tuberc. Lung Dis. 6 10 2002 903 908
16. D.A. Mitchison, and B.W. Allen Detection of rifampicin in urine by a simple microbiological assay Tuberculosis 51 1970 300 304
17. V. Pekovic, H. Mayanja, M. Vjecha, J. Johnson, A. Okwera, P. Nsubuga, R. Mugerwa, J. Ellner, and C. Whalen Comparison of three composite compliance indices in a trial of self-administered preventive therapy for tuberculosis in HIV-infected Ugandan adults J. Clin. Epidemiol. 51 1998 597 607
18. C.A. Peloquin Therapeutic drug monitoring in the treatment of tuberculosis Drugs 62 15 2002 2169 2183
19. J. Ray, I. Gardiner, and D. Marriot Managing antituberculosis drug therapy by therapeutic drug monitoring of rifampicin and isoniazid Int. Med. J. 33 2003 229 234
20. D.E. Schraufnagel, R. Stoner, E. Whiting, G. Snukst-Torbeck, and M.J. Werhane Testing for isoniazid - an evaluation of the Arkansas method Chest 98 1990 314 316
21. H.I. Seifart, W.L. Gent, D.P. Parkin, P.P. Van Jaarsveld, and P.R. Donald High-performance liquid chromatographic determination of isoniazid, acetylisoniazid and hydrazine in biological fluids J. Chromatogr. B: Biomed. Appl. 674 1995 269 275
22. F.A. Sirgel, P.R. Donald, J. Odhiambo, W. Githui, K.C. Umapsthy, C.N. Paramasivan, C.M. Tam, K.M. Kam, C.W. Lam, K.M. Sole, and D.A. Mitchison A multicentre study of the early bactericidal activity of antituberculosis drugs J. Antimic. Chem. 45 2000 859 870
23. F.A. Sirgel, P.B. Fourie, P.R. Donald, N. Padayatchi, R. Rustomjee, J. Levin, G. Roscigno, J. Norman, H. McIlleron, D.A. Mitchison The Rifapentine EBA Collaborative Study Group The early bactericidal activities of rifampin and rifapentine in pulmonary tuberculosis Am. J. Resp. Crit. Care. Med. 172 2005 128 135
24. P.J. Smith, J. van Dyk, and A. Fredericks Determination of rifampicin, isoniazid and pyrazinamide by high performance liquid chromatography after their simultaneous extraction from plasma Int. J. Tuberc. Lung Dis. 3 11 Suppl. 3 1999 S325 S328
25. R. Van Crewel, B. Alisjahbana, W.C.M. de Lange, F. Borst, H. Danusantoso, J.W.M. van der Meer, D. Burger, and R.H.H. Nelwan Low plasma concentrations of rifampicin in tuberculosis patients in Indonesia Int. J. Tuberc. Lung Dis. 6 6 2002 497 502
26. R. Whitfield, and G.F. Cope Point-of-care test to monitor adherence to anti-tuberculous treatment Ann. Clin. Biochem. 41 2004 411 413